Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study

AIMS: To investigate the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in patients with Type 2 diabetes mellitus inadequately controlled by a combination of metformin and pioglitazone. METHODS: This was a multi-centre, phase 3, randomized, double-blind, placebo-controlled s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajaj, M, Gilman, R, Patel, S, Kempthorne-Rawson, J, Lewis-D'Agostino, D, Woerle, H-J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257097/
https://www.ncbi.nlm.nih.gov/pubmed/24824197
http://dx.doi.org/10.1111/dme.12495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257097/
https://www.ncbi.nlm.nih.gov/pubmed/24824197
http://dx.doi.org/10.1111/dme.12495

Ejemplares similares